BioCentury
ARTICLE | Company News

Nastech Pharmaceutical Co. deal

July 18, 1994 7:00 AM UTC

DuPont Merck Pharmaceutical Co. licensed NSTK’s nasally delivered nalbuphine, a synthetic analgesic agent for the relief of moderate to severe pain. DuPont Merck received exclusive rights to develop t...